Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution

• Hyung Soon Park,

  Affiliations Department of Pharmacology and Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Sun Min Lim,

  Affiliation Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea

  ⨯
• Sora Kim,

  Affiliation Severance Biomedical Science Institute and Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Sangwoo Kim,

  Affiliation Severance Biomedical Science Institute and Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Hye Ryun Kim,

  Affiliation Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• KyuBum Kwack,

  Affiliation Department of Biomedical Science, College of Life Science, CHA University, Seongnam, Korea

  ⨯
• Min Goo Lee,

  Affiliation Department of Pharmacology and Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Joo-Hang Kim,

  Affiliation Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea

  ⨯
• Yong Wha Moon

  * E-mail: ymoon@cha.ac.kr

  Affiliation Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea

  ⨯